Skip to content

Efficacy and Safety Evaluation of Acupuncture at the Taichong Acupoint for Migraine Attacks: A Randomized Controlled Clinical Trial

Efficacy and Safety Evaluation of Acupuncture at the Taichong Acupoint for Migraine Attacks: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002050
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine without aura and Migraine with typical aura

Interventions

Experimental Group:Headache on one side is treated on the opposite side, and headache on both sides is treated on both sides. Procedure: The patient assumes a supine or seated position. The Taichong a
Control Group:The acupuncture protocol was the same as the experimental group, using a non-penetrating sham acupuncture control, with blunt-tipped needles, fixing a plastic pad on the skin, causing a

Sponsors

Beijing University of Chinese Medicine Dongzhimen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for migraine without aura or migraine with typical aura, and satisfies the unilateral, pulsating headache characteristics as specified in the diagnosis: This headache episode is a migraine attack and meets the unilateral, pulsating headache features; 2. The VAS score for this headache episode is =4; 3. The number of monthly migraine attacks is less than 15 days; 4. Aged 18-65 years (including 18 and 65 years), with an initial onset age less than 50 years, and has a history of migraine for more than one year; 5. Has not taken any migraine treatment medications within 24 hours of this episode, or the medications taken were ineffective; 6. Participants taking migraine preventive medications should have received a stable dose of no more than one preventive drug for at least 2 months prior to enrollment; 7. No prior acupuncture treatment; 8. The patient voluntarily participates and signs, or has a first-degree relative sign, the informed consent form. Note: For individuals where intracranial organic diseases cannot be ruled out, a cranial CT or MRI examination should be conducted to exclude headaches caused by intracranial organic diseases.

Exclusion criteria

Exclusion criteria: 1.Long-term users of painkillers or those dependent on painkillers (taking painkillers for more than 10 days within 1 month), or those with alcohol or drug abuse; 2. Patients with secondary headaches; 3.Patients who have undergone superficial temporal artery-middle cerebral artery anastomosis, superficial temporal artery ligation, or trauma to the pulsation site of the superficial temporal artery, making it impossible to complete superficial temporal artery ultrasound; 4. Patients with severe primary diseases of the cardiovascular, liver, kidney, digestive, or hematopoietic systems; 5. Patients with a history of epilepsy, stroke, or other organic neurological diseases, or a history of mental illness; 6. Patients with cognitive impairments who are unable to read or understand the content of the scale, unable to cooperate with medical treatment, may have poor compliance (i.e., unable to treatment), or are difficult to complete efficacy assessment; 7. Patients prone to infections, or those with skin diseases or skin damage at the acupuncture site; 8. Patients with a history of bleeding disorders caused by deficiency or dysfunction of clotting factors; 9. Pregnant and breastfeeding women; 10. Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
The percentage of patients whose headaches disappeared within 2 hours;

Secondary

MeasureTime frame
After acupuncture treatment for 2 hours, the change in headache severity VAS score compared to baseline.;After acupuncture treatment for 2 hours, the ratio of pain-free patients to those with headache relief (headache relief defined as no headache or mild headache).;The ratio of patients with persistent headache-free status to those with persistent headache relief from 2-hour to 24-hour.;Changes in VAS scores for pain in patients at the onset of a migraine attack and immediately after acupuncture treatment, as well as 5, 10, 20, 30, 45, 60, and 90 minutes, and 2, 3, 4, 6, 8, 24, and 48 hours after treatment.;At the onset of a migraine attack and immediately after acupuncture treatment, as well as 5, 10, 20, 30, 45, 60, and 90 minutes, and 2, 3, 4, 6, 8, 24, and 48 hours after treatment, the disappearance rate of the most bothersome accompanying symptoms, such as nausea, vomiting, photophobia, and phonophobia, compared to baseline in patients.;The 48-hour headache recurrence rate, defined as no pain occurring within 2 hours after treatment completion and the occurrence of headache of any intensity within 48 hours after acupuncture treatment.;The proportion of users of acute analgesics;Blind evaluation refers to, after treatment ends, asking patients to judge their group assignment based on their treatment experience, and comparing the results between the two groups to determine if there are inter-group differences.;

Countries

China

Contacts

Public ContactCao Ke Gang

Beijing University of Chinese Medicine Dongzhimen Hospital

kdoctor@sina.com13141229707

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026